middle.news
Star Combo Pharma Boosts Profit to $5.3M on 7% Revenue Growth in FY25
11:41pm on Friday 29th of August, 2025 AEST
•
Healthcare
Read Story
Star Combo Pharma Boosts Profit to $5.3M on 7% Revenue Growth in FY25
11:41pm on Friday 29th of August, 2025 AEST
Key Points
7% overall revenue growth to $27.8 million
10% increase in OEM and Own Brands revenue to $25.8 million
Profit before tax rises to $5.31 million from $1.0 million
Retail division revenue declines 25% amid store closures
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Star Combo Pharma (ASX:S66)
OPEN ARTICLE